Published in Anal Chem on April 01, 2005
High-resolution field asymmetric waveform ion mobility spectrometry using new planar geometry analyzers. Anal Chem (2006) 2.19
Protein analysis by shotgun/bottom-up proteomics. Chem Rev (2013) 2.13
Biomolecule analysis by ion mobility spectrometry. Annu Rev Anal Chem (Palo Alto Calif) (2008) 1.89
Two-dimensional gas-phase separations coupled to mass spectrometry for analysis of complex mixtures. Anal Chem (2005) 1.65
High-resolution differential ion mobility separations using helium-rich gases. Anal Chem (2010) 1.42
Overtone mobility spectrometry: part 1. Experimental observations. J Am Soc Mass Spectrom (2008) 1.32
High-resolution differential ion mobility separations using planar analyzers at elevated dispersion fields. Anal Chem (2010) 1.28
Assessing the dynamic range and peak capacity of nanoflow LC-FAIMS-MS on an ion trap mass spectrometer for proteomics. Anal Chem (2008) 1.24
Ultrafast differential ion mobility spectrometry at extreme electric fields in multichannel microchips. Anal Chem (2009) 1.20
Feasibility of higher-order differential ion mobility separations using new asymmetric waveforms. J Phys Chem A (2006) 1.18
Differential ion mobility separations of peptides with resolving power exceeding 50. Anal Chem (2010) 1.15
Overtone mobility spectrometry: part 2. Theoretical considerations of resolving power. J Am Soc Mass Spectrom (2009) 1.11
Improving FAIMS sensitivity using a planar geometry with slit interfaces. J Am Soc Mass Spectrom (2009) 1.10
Accelerated high-resolution differential ion mobility separations using hydrogen. Anal Chem (2011) 1.08
Separation and classification of lipids using differential ion mobility spectrometry. J Am Soc Mass Spectrom (2011) 1.07
Optimum waveforms for differential ion mobility spectrometry (FAIMS). J Am Soc Mass Spectrom (2008) 1.04
Ultrafast differential ion mobility spectrometry at extreme electric fields coupled to mass spectrometry. Anal Chem (2009) 1.04
Assessing the peak capacity of IMS-IMS separations of tryptic peptide ions in He at 300 K. Anal Chem (2007) 1.00
Ion mobility separation of isomeric phosphopeptides from a protein with variant modification of adjacent residues. Anal Chem (2011) 0.99
Pendular proteins in gases and new avenues for characterization of macromolecules by ion mobility spectrometry. Proc Natl Acad Sci U S A (2009) 0.95
Nanospray FAIMS fractionation provides significant increases in proteome coverage of unfractionated complex protein digests. Mol Cell Proteomics (2011) 0.92
Enhanced mixture analysis of poly(ethylene glycol) using high-field asymmetric waveform ion mobility spectrometry combined with fourier transform ion cyclotron resonance mass spectrometry. Anal Chem (2006) 0.92
Exploring crown ethers as shift reagents for ion mobility spectrometry. Anal Chem (2006) 0.91
To What Extent is FAIMS Beneficial in the Analysis of Proteins? J Am Soc Mass Spectrom (2016) 0.89
Probing the complementarity of FAIMS and strong cation exchange chromatography in shotgun proteomics. J Am Soc Mass Spectrom (2013) 0.86
Artificial neural networks for the prediction of peptide drift time in ion mobility mass spectrometry. BMC Bioinformatics (2010) 0.84
Review on ion mobility spectrometry. Part 2: hyphenated methods and effects of experimental parameters. Analyst (2015) 0.83
Recent findings and technological advances in phosphoproteomics for cells and tissues. Expert Rev Proteomics (2015) 0.81
High-field asymmetric waveform ion mobility spectrometry for mass spectrometry-based proteomics. Expert Rev Proteomics (2012) 0.80
Gridless overtone mobility spectrometry. Anal Chem (2013) 0.79
A preliminary study of metalloproteins in CSF by CapLC-ICPMS and NanoLC-CHIP/ITMS. J Proteome Res (2008) 0.79
The Highs and Lows of FAIMS: Predictions and Future Trends for High Field Asymmetric Waveform Ion Mobility Spectrometry. J Nanomed Nanotechnol (2012) 0.77
Characterization of Complete Histone Tail Proteoforms Using Differential Ion Mobility Spectrometry. Anal Chem (2017) 0.75
Prediction of peptide drift time in ion mobility mass spectrometry from sequence-based features. BMC Bioinformatics (2013) 0.75
Decreased Gap Width in a Cylindrical High-Field Asymmetric Waveform Ion Mobility Spectrometry Device Improves Protein Discovery. Anal Chem (2015) 0.75
Coupling Front-End Separations, Ion Mobility Spectrometry, and Mass Spectrometry for Enhanced Multidimensional Biological and Environmental Analyses. Annu Rev Anal Chem (Palo Alto Calif) (2017) 0.75
Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 3.97
Ptychographic X-ray computed tomography at the nanoscale. Nature (2010) 3.52
Biological imaging by soft x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2005) 2.79
Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol (2008) 2.58
Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol (2006) 2.11
Polo kinase regulates mitotic chromosome condensation by hyperactivation of condensin DNA supercoiling activity. Mol Cell (2009) 2.03
The phagosomal proteome in interferon-gamma-activated macrophages. Immunity (2009) 1.95
Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol (2008) 1.89
aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. EMBO J (2007) 1.81
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood (2012) 1.79
Quantitative biological imaging by ptychographic x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2009) 1.78
ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem (2010) 1.74
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med (2010) 1.69
The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci U S A (2005) 1.67
ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J (2006) 1.63
Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol Microbiol (2002) 1.58
The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell (2010) 1.44
H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet (2011) 1.43
N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40
Diffractive imaging of nonperiodic materials with future coherent X-ray sources. J Synchrotron Radiat (2004) 1.37
Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal Chem (2005) 1.34
A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics (2010) 1.34
The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med (2008) 1.31
Organelle proteomics: looking at less to see more. Trends Cell Biol (2003) 1.30
MYST protein acetyltransferase activity requires active site lysine autoacetylation. EMBO J (2011) 1.29
Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem (2002) 1.24
Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol (2005) 1.24
Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. EMBO J (2009) 1.21
Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol (2008) 1.19
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia (2003) 1.19
Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/Orbitrap mass spectrometer. J Proteome Res (2009) 1.17
Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor. PLoS One (2011) 1.16
Modulation of the phagosome proteome by interferon-gamma. Mol Cell Proteomics (2007) 1.15
Glycopeptide specificity of the secretory protein folding sensor UDP-glucose glycoprotein:glucosyltransferase. EMBO Rep (2003) 1.13
Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation. Sci Rep (2012) 1.11
An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture. Mol Cell Proteomics (2008) 1.09
Molecular characterization of the evolution of phagosomes. Mol Syst Biol (2010) 1.08
Cell cycle regulation of Greatwall kinase nuclear localization facilitates mitotic progression. J Cell Biol (2013) 1.08
Structure of the Rtt109-AcCoA/Vps75 complex and implications for chaperone-mediated histone acetylation. Structure (2011) 1.07
Comprehensive profiling of histone modifications using a label-free approach and its applications in determining structure-function relationships. Anal Chem (2008) 1.07
Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal Chem (2005) 1.05
Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood (2014) 1.04
A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics (2013) 1.04
The coming of age of phosphoproteomics--from large data sets to inference of protein functions. Mol Cell Proteomics (2013) 1.03
Occurrence and detection of phosphopeptide isomers in large-scale phosphoproteomics experiments. J Proteome Res (2012) 1.03
Identification of glycan structure and glycosylation sites in cellobiohydrolase II and endoglucanases I and II from Trichoderma reesei. Glycobiology (2002) 1.03
Drosophila S2 cells secrete wingless on exosome-like vesicles but the wingless gradient forms independently of exosomes. Traffic (2012) 1.03
Ptychographic characterization of the wavefield in the focus of reflective hard X-ray optics. Ultramicroscopy (2010) 1.01
Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J Biol Chem (2010) 1.01
Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol Syst Biol (2013) 0.99
Selective detection and identification of sugar nucleotides by CE-electrospray-MS and its application to bacterial metabolomics. Anal Chem (2004) 0.99
Origin and plasticity of MHC I-associated self peptides. Autoimmun Rev (2011) 0.99
Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling events of interferon-gamma-stimulated macrophages. Mol Cell Proteomics (2007) 0.97
Proteome analysis and functional expression identify mortalin as an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth muscle cells. Circ Res (2002) 0.97
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol (2011) 0.96
Kinetic characterization and identification of the acylation and glycosylation sites of recombinant human gamma-glutamyltranspeptidase. Biochemistry (2007) 0.96
Phosphorylation network rewiring by gene duplication. Mol Syst Biol (2011) 0.95
Improvement of phosphoproteome analyses using FAIMS and decision tree fragmentation. application to the insulin signaling pathway in Drosophila melanogaster S2 cells. J Proteome Res (2011) 0.94
Structure of extended lipopolysaccharide glycoforms containing two globotriose units in Haemophilus influenzae serotype b strain RM7004. Biochemistry (2003) 0.93
Application of microfluidic devices to proteomics research: identification of trace-level protein digests and affinity capture of target peptides. Mol Cell Proteomics (2002) 0.93
Transmission and emission x-ray microscopy: operation modes, contrast mechanisms and applications. J Phys Condens Matter (2011) 0.93
Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches. Mol Cell Proteomics (2013) 0.92
Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol Cell Proteomics (2010) 0.92
Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions. Mol Cell Proteomics (2013) 0.91
Quantitative proteomics reveals that only a subset of the endoplasmic reticulum contributes to the phagosome. Mol Cell Proteomics (2012) 0.91
Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC. J Biol Chem (2010) 0.91
Quantitative proteomics reveals the induction of mitophagy in tumor necrosis factor-α-activated (TNFα) macrophages. Mol Cell Proteomics (2013) 0.90
Near-field ptychography: phase retrieval for inline holography using a structured illumination. Sci Rep (2013) 0.90
A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production. J Virol (2013) 0.90
Artifactual sulfation of silver-stained proteins: implications for the assignment of phosphorylation and sulfation sites. Mol Cell Proteomics (2008) 0.89
ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses. Proteomics (2011) 0.89
Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology (2005) 0.89
Positive regulation of insulin signaling by neuraminidase 1. Diabetes (2013) 0.88
Sample preparation and analytical strategies for large-scale phosphoproteomics experiments. Semin Cell Dev Biol (2012) 0.88
6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer. Oncotarget (2013) 0.86
Chaperone-mediated acetylation of histones by Rtt109 identified by quantitative proteomics. J Proteomics (2012) 0.86
Proteomics analysis of herpes simplex virus type 1-infected cells reveals dynamic changes of viral protein expression, ubiquitylation, and phosphorylation. J Proteome Res (2013) 0.84
Subcellular phosphoproteomics. Mass Spectrom Rev (2010) 0.84
External and internal bone micro-architecture in normal and Kienböck's lunates: a whole-bone micro-computed tomography study. J Orthop Res (2014) 0.83